col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


143 Results       Page 1

 [1] 
Wiley: Journal of Internal Medicine
  original article Date Title Authors   Max. 6 Authors
1 [GO] 2023―Dec―31 Only as strong as the weakest link: Adrenal insufficiency in the COVID-19 storm Valeria Hasenmajer
2 [GO] 2023―Dec―13 Smells like a variant: How the association between COVID-19 and olfactory dysfunction changed between 2019 and 2022 Daniel D. DiLena, E. Margaret Warton, David R. Vinson, Marcos H. Siqueiros, Adina S. Rauchwerger, Dustin G. Mark, Jacek Skarbinski, S. Madhavi Cholleti, Edward J. Durant, Mary E. Reed, Dustin W. Ballard
3 [GO] 2023―Nov―29 Vagus nerve SARS-CoV-2 infection and inflammatory reflex dysfunction: Is there a causal relationship? Ulf Andersson, Kevin J. Tracey
4 [GO] 2023―Oct―18 Increased risk of hospitalization, intensive care and death due to COVID-19 in patients with adrenal insufficiency: A Swedish nationwide study Ragnhildur Bergthorsdottir, Daniela Esposito, Daniel S Olsson, Oskar Ragnarsson, Per Dahlqvist, Sophie Bensing, Jonatan Nåtman, Gudmundur Johannsson, Fredrik Nyberg
5 [GO] 2023―Oct―18 SARS-CoV-2 infection correlates with male benign prostatic hyperplasia deterioration Alex Qinyang Liu, Peter Ka-Fung Chiu, Samuel Chi-Hang Yee, Chi-Fai Ng, Jeremy Yuen-Chun Teoh
6 [GO] 2023―Sep―18 Circulating markers of extracellular matrix remodelling in severe COVID-19 patients Sarah Louise Murphy, Bente Halvorsen, Jan Cato Holter, Camilla Huse, Anders Tveita, Marius Trøseid, Hedda Hoel, Anders Benjamin Kildal, Aleksander Rygh Holten, Tøri Vigeland Lerum, Ole Henning Skjønsberg, Annika E. Michelsen, Trond M. Aaløkken, Kristian Tonby, Andreas Lind, Susanne Dudman, Beathe Kiland Granerud, Lars Heggelund, Simen Bøe, Anne Ma Dyrholt-Riise, Pål Aukrust, Andreas Barratt-Due, Thor Ueland, Tuva Børresdatter Dahl
7 [GO] 2023―Aug―18 UDCA treatment against COVID-19: Do we have enough clinical evidence for drug repurposing? Luisa Ojeda-Fernández, Marta Baviera, Giulia Macaluso, Simone Schena, Mauro Tettamanti, Massimo Cartabia, Andreana Foresta, Pier Manuccio Manucci, Alessandro Nobili, Giuseppe Remuzzi, Carla Roncaglioni
8 [GO] 2023―Jul―31 Incidence and determinants of venous thromboembolism over 90 days in hospitalized and nonhospitalized patients with COVID-19 Birgitte Tholin, Waleed Ghanima, Maria Lie Selle, Knut Stavem
9 [GO] 2023―Jul―20 Ursodeoxycholic acid for coronavirus disease 2019 prevention Kazuya Okushin, Makoto Kurano, Yutaka Yatomi, Kyoji Moriya, Mitsuhiro Fujishiro, Takeya Tsutsumi
10 [GO] 2023―Jul―10 Sociodemographic disparities affect COVID-19 vaccine uptake in non-elderly adults with increased risk of severe COVID-19 Pontus Hedberg, Adonis Sotoodeh, Helena H. Askling, Pontus Nauclér
11 [GO] 2023―Jun―18 Readmission and in-hospital death one year after COVID-19 hospitalization in South Africa Reitze Rodseth, Caroline Maslo, Anchen Laubscher, Richard Friedland
12 [GO] 2023―May―25 Impaired ACE2 glycosylation and protease activity in Fabry disease protects from COVID-19 Ilaria Caputo, Giovanni Bertoldi, Giulia Driussi, Luca Sgarabotto, Gianni Carraro, Lucia Federica Stefanelli, Paul A Davis, Lorenzo A Calò
13 [GO] 2023―Apr―28 Effective prognostic and clinical risk stratification in COVID-19 using multimodality biomarkers Alexander Liu, Robert Hammond, Peter D Donnelly, Juan Carlos Kaski, Anthony RM Coates
14 [GO] 2023―Apr―25 HIV-related mortality in the United States during the COVID-19 pandemic: A population-based study Xinyuan He, Fan Lv, Marissa Fox, Yee Hui Yeo, Biyao Zou, Jinli Liu, Yunyu Zhao, Jian Zu, Yan Li, Weiming Tang, Lei Zhang, Fanpu Ji
15 [GO] 2023―Apr―11 Residual pulmonary infiltrates, symptoms and diffusion impairment at one-year after severe COVID-19 infection have different associated factors Rosario Menéndez, Raúl Méndez, Ana Latorre, Paula González-Jiménez, Germán Peces-Barba, María Molina, Pedro Pablo España, Estela García, Angélica Consuegra-Vanegas, Ana Pando-Sandoval, Carolina Panadero, Juan Marco Figueira-Gonçalves, David De la Rosa, Oriol Sibila, María Dolores Martínez-Pitarch, Nuria Toledo, Pilar Cejudo, Wanda Almonte-Batista, Abigail Macías-Paredes, Diana Badenes, Eli Nancy Pérez-Rodas, Javier Lázaro, Sarai Quirós, Rosa Cordovilla, Irene Cano-Pumarega, Antoni Torres
16 [GO] 2023―Apr―07 SARS-CoV-2 antibody dynamics over time and risk factors associated with infection and long COVID-19 symptoms in large working environments Cecilie Bo Hansen, Kristina Dvoncova, Laura Pérez-Alós, Kamille Fogh, Johannes Roth Madsen, Caroline Hartwell Garred, Ida Jarlhelt, Pernille Brok Nielsen, Steffan Svejgaard Petersen, Charlotte Gandsø Fjordager, Klara Tølbøll Lauritsen, Linda Hilsted, Lasse Boding, Kasper Karmark Iversen, Liselotte Hyveled, Peter Garred
17 [GO] 2023―Apr―05 Ursodeoxycholic acid is associated with a reduction in SARS-CoV-2 infection and reduced severity of COVID-19 in patients with cirrhosis Binu V. John, Dustin Bastaich, Gwilym Webb, Teresa Brevini, Andrew Moon, Raphaella D. Ferreira, Allison M. Chin, David E. Kaplan, Tamar H. Taddei, Marina Serper, Nadim Mahmud, Yangyang Deng, Hann-Hsiang Chao, Fotios Sampaziotis, Bassam Dahman
18 [GO] 2023―Apr―02 Authors reply: Evaluation of SARS-CoV-2 antibody levels on hospital admission as a correlate of protection against mortality Sylvia Mink, Christoph H. Saely, Heinz Drexel, Peter Fraunberger
19 [GO] 2023―Apr―02 Regarding: Evaluation of SARS-CoV-2 antibody levels on hospital admission as a correlate of protection against mortality Shan Song
20 [GO] 2023―Mar―12 Human genetic and immunological determinants of SARS-CoV-2 and Epstein-Barr virus diseases in childhood: Insightful contrasts Qiang Pan-Hammarström, Jean-Laurent Casanova
21 [GO] 2023―Mar―08 Improving hospital outcomes using an acute hospital rehabilitation intensive service (ARISE) for patients with COVID-19 Erik H. Hoyer, Sowmya Kumble, April Pruski, Kelly N. Daley, Nicole Langton-Frost, Bhavesh Patel, Yisi Liu, Dhananjay Vaidya, Annette Lavezza, Pablo A. Celnik
22 [GO] 2023―Feb―23 Risk factors for impaired respiratory function post COVID-19: A prospective cohort study of nonhospitalized and hospitalized patients Tove Björsell, Josefin Sundh, Anna Lange, Clas Ahlm, Mattias N.E. Forsell, Staffan Tevell, Anders Blomberg, Alicia Edin, Johan Normark, Sara Cajander
23 [GO] 2023―Feb―05 SARS-CoV-2 antibody titers at the time of hospital admission and risk for mortality Hans-Gustaf Ljunggren
24 [GO] 2023―Jan―22 Evaluation of SARS-CoV-2 antibody levels on hospital admission as a correlate of protection against mortality Sylvia Mink, Wolfgang List, Guenter Hoefle, Matthias Frick, Alois Suessenbacher, Thomas Winder, Cornelia Fetz, Andreas Boesl, Christoph H. Saely, Heinz Drexel, Peter Fraunberger
25 [GO] 2023―Jan―17 The long and winding road of COVID-19 in survivors of hospitalization Murilo Bacchini Dias, Thiago J. Avelino-Silva, Márlon Juliano Romero Aliberti
26 [GO] 2023―Jan―13 Regarding: The long and winding road of COVID-19 in survivors of hospitalization Oscar M P Jolobe
27 [GO] 2023―Jan―10 Long-term durability of antibody responses after SARS-CoV-2 vaccination and influencing factors Joseph E. Ebinger, Sandy Y. Joung, Minhao Wang, Yunxian Liu, John C. Prostko, Edwin C. Frias, James L. Stewart, Jonathan Braun, Dermot P. B. McGovern, Gil Y. Melmed, Stanley C. Jordan, Brian L. Claggett, Kimia Sobhani, Susan Cheng
28 [GO] 2022―Dec―07 Post COVID-19 condition diagnosis: A population-based cohort study of occurrence, associated factors, and healthcare use by severity of acute infection Pontus Hedberg, Fredrik Granath, Judith Bruchfeld, Johan Askling, Daniel Sjöholm, Michael Fored, Anna Färnert, Pontus Naucler
29 [GO] 2022―Nov―28 Regarding: Factors associated with severe or fatal clinical manifestations of SARS-CoV-2 infection after receiving the third dose of vaccine Oscar Jolobe
30 [GO] 2022―Nov―16 The role of extracellular histones in COVID-19 Femke de Vries, Joram Huckriede, Kanin Wichapong, Chris Reutelingsperger, Gerry A.F. Nicolaes
31 [GO] 2022―Nov―14 A population-based, retrospective cohort study of the association between ABO blood group and risk of COVID-19 Torsten Dahlén, Huiqi Li, Fredrik Nyberg, Gustaf Edgren
32 [GO] 2022―Nov―01 The long and winding road of COVID-19 in survivors of hospitalisation: Symptoms trajectory and predictors of long COVID Murilo Bacchini Dias, Ana Paula Valeriano Medeiros, Sarah Santos de Melo, Cecilia Sella Fonseca, Wilson Jacob-Filho, Thiago J. Avelino-Silva, Márlon Juliano Romero Aliberti
33 [GO] 2022―Aug―24 Prevalence and 24-month recovery of olfactory dysfunction in COVID-19 patients: A multicenter prospective study Jerome R. Lechien, Luigi A. Vaira, Sven Saussez
34 [GO] 2022―Aug―23 Respiratory and systemic monocytes, dendritic cells and myeloid-derived suppressor cells in COVID-19: Implications for disease severity Sara Falck-Jones, Björn Österberg, Anna Smed-Sörensen
35 [GO] 2022―Aug―23 Factors influencing the immune response over 15 months after SARS-CoV-2 infection: A longitudinal population-wide study in the Faroe Islands Maria Skaalum Petersen, Laura Pérez-Alós, Jose Juan Almagro Armenteros, Cecilie Bo Hansen, Jógvan Páll Fjallsbak, Sólrun Larsen, Jóhanna Ljósá Hansen, Ida Jarlhelt, Marnar Fríheim Kristiansen, Fríða við Streym, Bjarni á Steig, Debes Hammershaimb Christiansen, Lars Fodgaard Møller, Marin Strøm, Guðrið Andorsdóttir, Shahin Gaini, Pál Weihe, Peter Garred
36 [GO] 2022―Aug―19 Persistent T-cell exhaustion in relation to prolonged pulmonary pathology and death after severe COVID-19: Results from two Norwegian cohort studies Marius Trøseid, Tuva B. Dahl, Jan C. Holter, Anders B. Kildal, Sarah L. Murphy, Kuan Yang, Ana Quiles-Jiménez, Lars Heggelund, Karl Erik Müller, Anders Tveita, Annika E. Michelsen, Simen Bøe, Aleksander R. Holten, Hedda Hoel, Alexander Mathiessen, Trond M. Aaløkken, Børre Fevang, Beathe K. Granerud, Kristian Tonby, Katerina N. Henriksen, Tøri V. Lerum, Fredrik Müller, Ole H. Skjønsberg, Andreas Barratt-Due, Anne M. Dyrhol-Riise, Pål Aukrust, Bente Halvorsen, Thor Ueland
37 [GO] 2022―Aug―10 Incidence of SARS-CoV-2 infection among unvaccinated US adults during the Omicron wave Jennifer L. Alejo, Teresa PY Chiang, Jonathan Mitchell, Aura T. Abedon, Alexa A. Jefferis, William Werbel, Allan B. Massie, Martin A. Makary, Dorry L. Segev
38 [GO] 2022―Aug―09 Factors associated with severe or fatal clinical manifestations of SARS-CoV-2 infection after receiving the third dose of vaccine Giovanni Corrao, Matteo Franchi, Danilo Cereda, Francesco Bortolan, Olivia Leoni, Jose Jara, Giuseppina Valenti, Giovanni Pavesi
39 [GO] 2022―Jul―23 Increased mortality of patients with alcohol-related liver diseases during the COVID-19 pandemic in the United States Yee Hui Yeo, Biyao Zou, Ramsey Cheung, Mindie H. Nguyen
40 [GO] 2022―Jul―08 Vitamin D and COVID-19 - revisited Sreedhar Subramanian, George Griffin, Martin Hewison, Julian Hopkin, Rose Anny Kenny, Eamon Laird, Richard Quinton, David Thickett, Jonathan Rhodes
41 [GO] 2022―Jul―04 Early SARS-CoV-2 associated acute transverse myelitis: A case for neurotropism? Irene F. Lu, Jack S. Cornish, Aadith Ashok, Siew Kar Chen, Eugene Athan, Andrew Hughes
42 [GO] 2022―May―25 Severe COVID-19 in people 55 and older during the first year of the pandemic in Sweden A. Rosengren, C. E. Lundberg, M. Söderberg, A. Santosa, J. Edqvist, M. Lindgren, M. Åberg, M. Gisslén, J. Robertson, O. Cronie, N. Sattar, J. Lagergren, M. Brandén, J. Björk, M. Adiels
43 [GO] 2022―May―25 Three doses of mRNA COVID-19 vaccine protects from SARS-CoV-2 infections in Japan Katsuyuki Hotta, Etsuji Suzuki, Eiki Ichihara, Katsuyuki Kiura
44 [GO] 2022―May―23 Randomized clinical trial of BCG vaccine in patients with convalescent COVID-19: Clinical evolution, adverse events, and humoral immune response Mehrsa Jalalizadeh, Keini Buosi, Franciele A. V. Dionato, Luciana S.B. Dal Col, Cristiane F. Giacomelli, Karen L. Ferrari, Ana Carolina Pagliarone, Patrícia A.F. Leme, Cristiane L. Maia, Reza Yadollahvandmiandoab, Quoc-Dien Trinh, Kleber G. Franchini, Marcio C. Bajgelman, Leonardo O. Reis
45 [GO] 2022―May―09 Adults hospitalized with breakthrough COVID-19 have lower mortality than matched unvaccinated adults Laura C. Myers, Patricia Kipnis, John Greene, Brian Lawson, Gabriel J. Escobar, Bruce H. Fireman, Nicola P. Klein, Vincent X. Liu
46 [GO] 2022―Apr―13 Detailed characterization of hospitalized patients infected with the Omicron variant of SARS-CoV-2 Errol Ozdalga, Neera Ahuja, Niraj Sehgal, Jason Hom, Yingjie Weng, Benjamin Pinsky, Kevin A. Schulman, William Collins
47 [GO] 2022―Apr―12 COVID-19 in Latin America and the Caribbean: Two years of the pandemic Alvaro Schwalb, Eleonora Armyra, Melissa Méndez-Aranda, César Ugarte-Gil
48 [GO] 2022―Apr―05 Variations in end-of-life care practices in older critically ill patients with COVID-19 in Europe Bernhard Wernly, Richard Rezar, Hans Flaatten, Michael Beil, Jesper Fjølner, Raphael Romano Bruno, Antonio Artigas, Bernardo Bollen Pinto, Joerg C. Schefold, Malte Kelm, Sviri Sigal, Peter Vernon Heerden, Wojciech Szczeklik, Muhammed Elhadi, Michael Joannidis, Sandra Oeyen, Georg Wolff, Brian Marsh, Finn H. Andersen, Rui Moreno, Susannah Leaver, Sarah Wernly, Ariane Boumendil, Dylan W. De Lange, Bertrand Guidet, Christian Jung
49 [GO] 2022―Mar―15 1-year persistent symptoms and functional impairment in SARS-CoV-2 positive and negative individuals Mayssam Nehme, Olivia Braillard, François Chappuis, Delphine S. Courvoisier, Laurent Kaiser, Idris Guessous, Mayssam Nehme, Idris Guessous, François Chappuis, Laurent Kaiser, Olivia Braillard, Delphine S. Courvoisier, Paola M. Soccal, Jean-Luc Reny, Frederic Assal, Guido Bondolfi, Aglaé Tardin, Christophe Graf, Dina Zekry, Silvia Stringhini, Hervé Spechbach, Frederique Jacquerioz, Julien Salamun, Frederic Lador, Matteo Coen, Thomas Agoritsas, Lamyae Benzakour, Riccardo Favale, Stéphane Genevay, Kim Lauper, Philippe Meyer, Nana Kwabena Poku, Basile N. Landis, Stéphanie Baggio, Marwène Grira, José Sandoval, Julien Ehrsam, Simon Regard, Camille Genecand, Garance Kopp, Ivan Guerreiro, Gilles Allali, Pauline Vetter
50 [GO] 2022―Mar―07 Incidence and severity of COVID-19 in adults with and without HIV diagnosis Pontus Hedberg, Jan Vesterbacka, Ola Blennow, Catharina Missailidis, Piotr Nowak, Pontus Naucler
51 [GO] 2022―Feb―25 Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations Beate Vestad, Thor Ueland, Tøri Vigeland Lerum, Tuva Børresdatter Dahl, Kristian Holm, Andreas Barratt-Due, Trine Kåsine, Anne Ma Dyrhol-Riise, Birgitte Stiksrud, Kristian Tonby, Hedda Hoel, Inge Christoffer Olsen, Katerina Nezvalova Henriksen, Anders Tveita, Ravinea Manotheepan, Mette Haugli, Ragnhild Eiken, Åse Berg, Bente Halvorsen, Tove Lekva, Trine Ranheim, Annika Elisabeth Michelsen, Anders Benjamin Kildal, Asgeir Johannessen, Lars Thoresen, Hilde Skudal, Bård Reiakvam Kittang, Roy Bjørkholt Olsen, Carl Magnus Ystrøm, Nina Vibeche Skei, Raisa Hannula, Saad Aballi, Reidar Kvåle, Ole Henning Skjønsberg, Pål Aukrust, Johannes Roksund Hov, Marius Trøseid
52 [GO] 2022―Feb―23 Low anti-spike antibody levels correlate with poor outcomes in COVID-19 breakthrough hospitalizations Devang K. Sanghavi, Shivang Bhakta, Hani M. Wadei, Wendelyn Bosch, Jennifer B. Cowart, Rickey E. Carter, Sadia Z. Shah, Benjamin D. Pollock, Matthew R. Neville, Sven P. Oman, Leigh Speicher, Jason Siegel, Ameya D. Scindia, Claudia R. Libertin, Katie L. Kunze, Patrick W. Johnson, Mark W. Matson, Pablo Moreno Franco
53 [GO] 2022―Feb―16 Acute odynophagia - a new symptom of COVID-19 during the SARS-CoV-2 Omicron variant wave in Sweden Krzysztof Piersiala, Lara Kakabas, Anna Bruckova, Magnus Starkhammar, Lars Olaf Cardell
54 [GO] 2022―Feb―03 The first wave of COVID-19 and concurrent social restrictions were not associated with a negative impact on mental health and psychiatric well-being Thorvardur Jon Love, Inga Wessman, Gauti Kjartan Gislason, Saemundur Rognvaldsson, Sigrun Thorsteinsdottir, Gudrun Asta Sigurdardottir, Asdis Rosa Thordardottir, Elias Eythorsson, Tinna Laufey Asgeirsdottir, Thor Aspelund, Andri Steinthor Bjornsson, Sigurdur Yngvi Kristinsson
55 [GO] 2022―Jan―19 Post-Covid-19-vaccination adverse events and healthcare utilization among individuals with or without previous SARS-CoV-2 infection Francisco Tsz Tsun Lai, Lei Huang, Kuan Peng, Xue Li, Celine Sze Ling Chui, Eric Yuk Fai Wan, Carlos King Ho Wong, Esther Wai Yin Chan, Ivan Fan Ngai Hung, Ian Chi Kei Wong
56 [GO] 2021―Dec―07 COVID-19 hospitalization is associated with pulmonary / diffusion abnormalities but not post-acute sequelae of COVID-19 severity Grace Y. Lam, A. Dean Befus, Ronald W. Damant, Giovanni Ferrara, Desi P. Fuhr, Cheryl R. Laratta, Angela Lau, Michael K. Stickland, Rhea A. Varughese, Eric Y. Wong, Maeve P. Smith
57 [GO] 2021―Dec―07 Impaired ACE2 glycosylation and protease activity lowers COVID-19 susceptibility in Gitelman's and Bartter's syndromes Giovanni Bertoldi, Verdiana Ravarotto, Luca Sgarabotto, Paul A Davis, Laura Gobbi, Lorenzo A Calò
58 [GO] 2021―Nov―15 Authors reply: Hypoalbuminemia in COVID-19 M. A. Wu, R. Colombo
59 [GO] 2021―Nov―15 Hypoalbuminemia in COVID-19 D. Lapenna
60 [GO] 2021―Nov―01 Effectiveness of REGEN-COV antibody cocktail against the B.1.617.2 (delta) variant of SARS-CoV-2: A cohort study Jagadeesh Kumar V, Sofia Banu, Mitnala Sasikala, Kishore V. L. Parsa, Divya Tej Sowpati, Rupali Yadav, Karthik Bharadwaj Tallapaka, Archana Bharadwaj Siva, Ravikanth Vishnubhotla, G. V. Rao, Duvvur Nageshwar Reddy
61 [GO] 2021―Oct―29 Lp(a) and SARS-CoV-2: A conspiracy of two mysteries Byambaa Enkhmaa, Lars Berglund
62 [GO] 2021―Oct―08 Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients María Martin-Vicente, Raquel Almansa, Isidoro Martínez, Ana P. Tedim, Elena Bustamante, Luis Tamayo, César Aldecoa, José Manuel Gómez, Gloria Renedo, Jose Ángel Berezo, Jamil Antonio Cedeño, Nuria Mamolar, Pablo García Olivares, Rubén Herrán-Monge, Ramón Cicuendez, Pedro Enríquez, Alicia Ortega, Noelia Jorge, Cristina Doncel, Amanda de la Fuente, Juan Bustamante-Munguira, María José Muñoz-Gómez, Milagros González-Rivera, Carolina Puertas, Vicente Más, Mónica Vázquez, Felipe Pérez-García, Jesús Rico-Feijoo, Silvia Martín, Anna Motos, Laia Fernandez-Barat, Jose María Eiros, Marta Dominguez-Gil, Ricard Ferrer, Ferrán Barbé, Wysali Trapiello, David J. Kelvin, Jesús F. Bermejo-Martin, Salvador Resino, Antoni Torres
63 [GO] 2021―Sep―27 Long-term neuropsychiatric outcomes in COVID-19 survivors: A 1-year longitudinal study Raúl Méndez, Vicent Balanzá-Martínez, Sussy C. Luperdi, Itziar Estrada, Ana Latorre, Paula González-Jiménez, Leyre Bouzas, Katheryn Yépez, Ana Ferrando, Soledad Reyes, Rosario Menéndez
64 [GO] 2021―Aug―30 Low incidence of non-COVID-19 community respiratory viral infections amongst adults with hematological malignancies during the COVID-19 pandemic Jing Yuan Tan, Edwin Philip Conceicao, Liang En Wee, Heng Joo Ng, Indumathi Venkatachalam
65 [GO] 2021―Aug―30 Robust humoral and cellular immune responses and low risk for reinfection at least eight months following asymptomatic to mild COVID-19 Sebastian Havervall, Henry Ng, August Jernbom Falk, Nina Greilert-Norin, Anna Månberg, Ulrika Marking, Ida Laurén, Lena Gabrielsson, Ann-Christin Salomonsson, Katherina Aguilera, Martha Kihlgren, Maja Månsson, Axel Rosell, Cecilia Hellström, Eni Andersson, Jennie Olofsson, Lovisa Skoglund, Jamil Yousef, Elisa Pin, Martin Lord, Mikael Åberg, My Hedhammar, Hanna Tegel, Pierre Dönnes, Mia Phillipson, Peter Nilsson, Jonas Klingström, Sara Mangsbo, Sophia Hober, Charlotte Thålin
66 [GO] 2021―Aug―26 Bowel ischemia as onset of COVID-19 in otherwise asymptomatic patients with persistently negative swab Paolo Zamboni, Daria Bortolotti, Savino Occhionorelli, Luca Traina, Luca Maria Neri, Roberta Rizzo, Roberta Gafà, Angelina Passaro
67 [GO] 2021―Aug―19 Neutrophil count predicts clinical outcome in hospitalized covid-19 patients: Results from the NOR-Solidarity trial Trine Kåsine, Anne Ma Dyrhol-Riise, Andreas Barratt-Due, Anders Benjamin Kildal, Inge Christoffer Olsen, Katerina Nezvalova Henriksen, Fridtjof Lund-Johansen, Hedda Hoel, Aleksander Rygh Holten, Anders Tveita, Alexander Mathiessen, Mette Haugli, Ragnhild Eiken, Åse ÅseBerg, Asgeir Johannessen, Lars Heggelund, Tuva Børresdatter Dahl, Bente Halvorsen, Pawel Mielnik, Lan Ai Kieu Le, Lars Thoresen, Gernot Ernst, Dag Arne Lihaug Hoff, Hilde Skudal, Bård Reiakvam Kittang, Roy Bjørkholt Olsen, Birgitte Tholin, Carl Magnus Ystrøm, Nina Vibeche Skei, Raisa Hannula, Olav Dalgard, Ane-Kristine Finbråten, Kristian Tonby, Saad Aballi, Fredrik Müller, Kristin Greve-Isdahl Mohn, Marius Trøseid, Pål Aukrust, Thor Ueland
68 [GO] 2021―Aug―05 Immunity to SARS-CoV-2 induced by infection or vaccination Xaquin Castro Dopico, Sebastian Ols, Karin Loré, Gunilla B. Karlsson Hedestam
69 [GO] 2021―Jul―16 Self-infection with speech aerosol may contribute to COVID-19 severity Poorna Kushalnagar, Carson C. Chow, Adriaan Bax
70 [GO] 2021―Jul―08 Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 priming Cecilie Bo Hansen, Ida Jarlhelt, Rasmus Bo Hasselbalch, Sebastian Rask Hamm, Kamille Fogh, Mia Marie Pries-Heje, Dina Leth Møller, Line Dam Heftdal, Laura Pérez-Alós, Erik Sørensen, Margit Anita Hørup Larsen, Mikkel-Ole Skjoedt, Sisse Rye Ostrowski, Ruth Frikke-Schmidt, Rafael Bayarri-Olmos, Linda Maria Hilsted, Henning Bundgaard, Susanne Dam Nielsen, Kasper Karmark Iversen, Peter Garred
71 [GO] 2021―Jul―08 Body weight, body composition and the risk of SARS-CoV-2 infection in a large population-based sample Mélanie Deschasaux-Tanguy, Laurent Bourhis, Xavier Lamballerie, Fabrice Carrat, Mathilde Touvier
72 [GO] 2021―Jul―08 Immunogenicity of SARS-CoV-2 mRNA vaccine in solid organ transplant recipients Inge K. Holden, Claus Bistrup, Anna Christine Nilsson, Janne Fuglsang Hansen, Rozeta Abazi, Jesper Rømhild Davidsen, Mikael Kjær Poulsen, Susan Olaf Lindvig, Ulrik S. Justesen, Isik Somuncu Johansen
73 [GO] 2021―Jun―16 Mucormycosis and glucose-regulated protein 78 in COVID-19: amenable to statin treatment? Alpo Vuorio, Petri T. Kovanen
74 [GO] 2021―Jun―10 Truths and fakes in the smell terminology during the COVID-19 outbreak B. Arana-Fernández, A. Santamaría-Gadea, F. Mariño-Sánchez, J. Mullol
75 [GO] 2021―Jun―09 Mental health and quality of life in COVID-19 survivors: a needed discussion Sophia De Moraes De Medeiros, Raílla Vandresen, Elonir Gomes, Eliane Mazzuco
76 [GO] 2021―Jun―09 Breathing, speaking, coughing or sneezing: What drives transmission of SARS-CoV-2? V. Stadnytskyi, P. Anfinrud, A. Bax
77 [GO] 2021―Jun―07 Lipoprotein(a) and SARS-CoV-2 infections: susceptibility to infections, ischemic heart disease and thromboembolic events Silvia Di Maio, Claudia Lamina, Stefan Coassin, Lukas Forer, Reinhard Würzner, Sebastian Schönherr, Florian Kronenberg
78 [GO] 2021―Jun―04 Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns E. E. Christensen, M. J. Jørgensen, K. G. Nore, T. B. Dahl, K. Yang, T. Ranheim, C. Huse, A. Lind, S. Nur, B. Stiksrud, S. Jenum, K. Tonby, J. C. Holter, A. R. Holten, B. Halvorsen, A. M. Dyrhol-Riise
79 [GO] 2021―May―28 What drives transmission of severe acute respiratory syndrome coronavirus 2? Jan Andersson
80 [GO] 2021―May―19 Seropositivity in blood donors and pregnant women during the first year of SARS-CoV-2 transmission in Stockholm, Sweden X. Castro Dopico, S. Muschiol, M. Christian, L. Hanke, D. J. Sheward, N. F. Grinberg, J. Rorbach, G. Bogdanovic, G. M. Mcinerney, T. Allander, C. Wallace, B. Murrell, J. Albert, G. B. Karlsson Hedestam
81 [GO] 2021―Apr―27 Half-year follow-up of patients recovering from severe COVID-19: Analysis of symptoms and their risk factors Y. F. Shang, T. Liu, J. N. Yu, X. R. Xu, K. R. Zahid, Y. C. Wei, X. H. Wang, F. L. Zhou
82 [GO] 2021―Apr―19 Cause of death based on systematic postmortem studies in patients with positive SARS-CoV2 tissue PCR during the COVID-19 pandemic Elena S. Romanova, Valery V. Vasilyev, Galina Startseva, Vadim Karev, Margarita G. Rybakova, Pyotr G. Platonov
83 [GO] 2021―Apr―12 SARS-CoV-2 infections amongst personnel providing home care services for older persons in Stockholm, Sweden S. S. Hassan, Å. Seigerud, R. Abdirahman, L. S. Arroyo Mühr, S. Nordqvist Kleppe, E. Pin, A. Månberg, S. Hober, P. Nilsson, L. Engstrand, K. Miriam Elfström, J. Blomqvist, K. Conneryd Lundgren, J. Dillner
84 [GO] 2021―Apr―06 Reply letter to: Inhibition of SARS-CoV-2 replication using calcineurin inhibitors: Are concentrations required clinically achievable? J. L. Gálvez-Romero, J. Deveaux-Homs, F. A. Real-Ramírez, O. Palmeros-Rojas, S. Pedraza-Sánchez
85 [GO] 2021―Apr―05 Psychophysical evaluations are important, usefulness and usability approaches to study the smell disorder related to COVID-19 Sven Saussez, Stéphane Hans, Carlos M. Chiesa-Estomba, Jerome R. Lechien
86 [GO] 2021―Mar―31 Cholestatic liver injury in COVID-19 is a rare and distinct entity and is associated with increased mortality Ben L. Da, Kelly Suchman, Nitzan Roth, Anam Rizvi, Maria Vincent, Arvind J. Trindade, David Bernstein, Sanjaya K. Satapathy
87 [GO] 2021―Mar―13 Post-acute cognitive and mental health outcomes amongst COVID-19 survivors: early findings and a call for further investigation T. Vannorsdall, E. S. Oh
88 [GO] 2021―Mar―13 Impact of COVID-19 pandemic on the medical activities of the Directorate of Health and Hygiene, Vatican City State Massimo Ralli, Andrea Arcangeli, Paolo Maurizio Soave, Luigi Carbone, Lucia Ercoli, Fabio De-Giorgio
89 [GO] 2021―Mar―02 Arterial stiffness in acute COVID-19 and potential associations with clinical outcome Sebastian Schnaubelt, Julia Oppenauer, Daniel Tihanyi, Markus Mueller, Eduardo Maldonado-Gonzalez, Sara Zejnilovic, Helmuth Haslacher, Thomas Perkmann, Robert Strassl, Sonja Anders, Thomas Stefenelli, Sonja Zehetmayer, Renate Koppensteiner, Hans Domanovits, Oliver Schlager
90 [GO] 2021―Feb―26 Inhibition of SARS-CoV-2 replication using calcineurin inhibitors: are concentrations required clinically achievable? X. Solanich, N. Padullés, J. Niubó, S. Videla, A. Antolí, G. Rocamora-Blanch, X. Corbella
91 [GO] 2021―Feb―10 Chest pain mimicking pulmonary embolism may be a common presentation of COVID-19 in ambulant patients without other typical features of infection Stephanie R Harrison, Joel RL Klassen, Charlie Bridgewood, Andrew Scarsbrook, Helena Marzo-Ortega, Dennis McGonagle
92 [GO] 2021―Feb―10 The development of preprints during the COVID-19 pandemic Andreas Älgå, Oskar Eriksson, Martin Nordberg
93 [GO] 2021―Feb―06 Short-term Neuropsychiatric Outcomes and Quality of Life in COVID-19 Survivors Raúl Méndez, Vicent Balanzá-Martínez, Sussy C. Luperdi, Itziar Estrada, Ana Latorre, Paula González-Jiménez, Laura Feced, Leyre Bouzas, Katheryn Yépez, Ana Ferrando, David Hervás, Enrique Zaldívar, Soledad Reyes, Michael Berk, Rosario Menéndez
94 [GO] 2021―Feb―03 Pathophysiological Mechanisms and Management of Patients with Long-time Anosmia related to COVID-19 Jerome R. Lechien, Carlos M. Chiesa-Estomba, Stéphane Hans, Sven Saussez
95 [GO] 2021―Feb―03 Clinical Features of Patients who had two COVID-19 Episodes: A European Multicenter Case-series Jerome R. Lechien, Carlos M. Chiesa-Estomba, Thomas Radulesco, Justin Michel, Luigi A. Varia, Serge D. Le Bon, Mihaela Horoi, Chiara Falanga, Maria R. Barillari, Stephane Hans, Manuel Tucciarone, Sven Saussez
96 [GO] 2021―Jan―29 Tocilizumab in COVID-19 interstitial pneumonia G. Pomponio, A. Ferrarini, M. Bonifazi, M. Moretti, A. Salvi, A. Giacometti, M. Tavio, G. Titolo, L. Morbidoni, G. Frausini, M. Onesta, D. Amico, M. L. B. Rocchi, S. Menzo, L. Zuccatosta, F. Mei, V. Menditto, S. Svegliati, A. Donati, M. M. D'Errico, M. Pavani, A. Gabrielli
97 [GO] 2021―Jan―27 Blood Group A Epitopes do not Facilitate Entry of SARS-CoV-2 Johannes Schetelig, Henning Baldauf, Sarah Wendler, Falk Heidenreich, Ruben Real, Martin Kolditz, Andrea Rosner, Alexander Dalpke, Katja de With, Vinzenz Lange, Jan Markert, Ralf Barth, Carolin Bunzel, Dennis Endert, Jan A Hofmann, Jürgen Sauter, Stefanie N Bernas, Alexander H Schmidt
98 [GO] 2021―Jan―19 Long-term recovery from COVID-19 anosmia: promising findings and unanswered questions Locatello Luca Giovanni, Oreste Gallo
99 [GO] 2021―Jan―19 Outcomes of COVID-19 Positive Acute Coronary Syndrome Patients; a multisource Electronic Healthcare Records Study from England Muhammad Rashid, Jianhua Wu, Adam Timmis, Nick Curzen, Sarah Clarke, Azfar Zaman, James Nolan, Ahmad Shoaib, Mohamed O Mohamed, Mark A de Belder, John Deanfield, Chris P Gale, Mamas A. Mamas
100 [GO] 2021―Jan―16 Assessment of Thirty-Day Readmission Rate, Timing, Causes, and Predictors after Hospitalization with COVID-19 Ilhwan Yeo, Seunghyup Baek, JoonHyuk Kim, Hadya Elshakh, Angelina Voronina, Man Si Lou, Joshua Vapnik, Ravinder Kaler, Xuming Dai, Seth Goldbarg
101 [GO] 2021―Jan―16 Increased vulnerability to Covid-19 in chronic kidney disease Nicholas Carlson, Karl-Emil Nelveg-Kristensen, Ellen Freese Ballegaard, Bo Feldt-Rasmussen, Mads Hornum, Anne-Lise Kamper, Gunnar Gislason, Christian Torp-Pedersen
102 [GO] 2021―Jan―10 Hypoalbuminemia in COVID-19: assessing the hypothesis for underlying pulmonary capillary leakage M. A. Wu, T. Fossali, L. Pandolfi, L. Carsana, D. Ottolina, V. Frangipane, R. Rech, A. Tosoni, G. Lopez, A. Agarossi, C. Cogliati, F. Meloni, B. Marchini, M. Nebuloni, E. Catena, R. Colombo
103 [GO] 2021―Jan―07 Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients J. R. Lechien, C. M. Chiesa-Estomba, E. Beckers, V. Mustin, M. Ducarme, F. Journe, A. Marchant, L. Jouffe, M. R. Barillari, G. Cammaroto, M. P. Circiu, S. Hans, S. Saussez
104 [GO] 2020―Dec―29 Chronic rhinosinusitis is associated with prolonged SARS-CoV2 RNA shedding in upper respiratory tract samples: A case-control study B Recalde-Zamacona, A Tomás-Velázquez, A Campo, B Satrústegui-Alzugaray, M Fernández-Alonso, M Iñigo, M Rodríguez-Mateos, M Di Frisco, C Felgueroso, J Bertó, M Marín-Oto, AB Alcaide, JJ Zulueta, L Seijo, MF Landecho
105 [GO] 2020―Dec―20 Gastrointestinal Bleeding in Hospitalized COVID-19 Patients: A Propensity Score Matched Cohort Study Arvind J Trindade, Stephanie Izard, Kevin Coppa, Jamie S Hirsch, Calvin Lee, Sanjaya K Satapathy, Matthew A Barish, Ernesto P Molmenti, David E Bernstein
106 [GO] 2020―Dec―11 The association between blood groups and COVID-19 infection: a study from the UK Biobank Jufen Zhang, Pierpaolo Pellicori, Rudolph Schutte, John G. Cleland
107 [GO] 2020―Dec―04 Cyclosporine A plus low-dose steroid treatment in COVID-19 improves clinical outcomes in patients with moderate to severe disease. A pilot study Jose Luis Galvez-Romero, Oscar Palmeros-Rojas, Fernando Antonio Real-Ramírez, Saúl Sánchez-Romero, Ramiro Tome-Maxil, María Patricia Ramírez-Sandoval, Rosaura Olivos-Rodríguez, Salvador Eduardo Flores-Encarnación, Ana América Cabrera-Estrada, José Ávila-Morales, Víctor Cortés-Sánchez, Gonzalo Sarmiento-Padilla, Sandra Elizabeth Tezmol-Ramírez, David Aparicio-Hernández, Mario Iván Urbina-Sánchez, Miguel Ángel Gómez-Pluma, Surizadith Cisneros-Méndez, Dinorah Ivonne Rodríguez-Rivas, Sergio Reyes-Inurrigarro, Gilberto Cortés-Díaz, Carlos Cruz-Delgado, Jaqueline Navarro-González, José Deveaux-Homs, Sigifredo Pedraza-Sánchez
108 [GO] 2020―Dec―03 Tobacco smoking confers risk for severe COVID-19 unexplainable by pulmonary imaging J. Li, X. Long, Q. Zhang, X. Fang, N. Li, B. Fedorova, S. Hu, Jh. Li, N. Xiong, Z. Lin
109 [GO] 2020―Dec―01 Direct oral anticoagulant use and risk of severe COVID-19 Benjamin Flam, Viktor Wintzell, Jonas F. Ludvigsson, Johan Mårtensson, Björn Pasternak
110 [GO] 2020―Nov―22 PCSK9 inhibitors for COVID-19: An opportunity to enhance the antiviral action of interferon in patients with hypercholesterolemia Alpo Vuorio, Petri T. Kovanen
111 [GO] 2020―Nov―19 ACE-Inhibitors, Angiotensin Receptor Blockers and Endothelial Injury in COVID-19 Simon Tetlow, Agnieszka Segiet-Swiecicka, Rebecca O’Sullivan, Sinead O’Halloran, Kelli Kalb, Charlotte Brathwaite-Shirley, Laura Alger, Akshay Ankuli, Mirza Shaheer Baig, Fergus Catmur, Torbert Chan, Declan Dudley, Joshua Fisher, Muhammad Usman Iqbal, Joanna Puczynska, Ryan Wilkins, Rachael Bygate, Peter Roberts
112 [GO] 2020―Nov―09 Insights into Disparities Observed with COVID-19 John M. Carethers
113 [GO] 2020―Nov―03 A potential link between RAAS, obesity and atrial fibrillation in COVID-19 infection O. M. P. Jolobe
114 [GO] 2020―Oct―27 On the relationship between BCG coverage and national Covid-19 outcome: could “heterologous” herd immunity explain why some countries are better off? Maria Lerm
115 [GO] 2020―Oct―20 Thinking about tuberculosis in times of Covid-19 Rosarito Coronel Teixeira, Sarita Aguirre, Domingo Pérez Bejarano
116 [GO] 2020―Oct―20 Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID-19: a meta-analysis C. S. Kow, S. S. Hasan
117 [GO] 2020―Oct―09 Clinical predictors of donor antibody titer and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial Maria Lucia L. Madariaga, Jenna J. Guthmiller, Stephen Schrantz, Maud O. Jansen, Chancey Christensen, Madan Kumar, Micah Prochaska, Geoffrey Wool, Amy Durkin-Celauro, Won Hee Oh, Laura Trockman, Janani Vigneswaran, Robert Keskey, Dustin G. Shaw, Haley Dugan, Nai-Ying Zheng, Mari Cobb, Henry Utset, Jiaolong Wang, Olivia Stovicek, Cindy Bethel, Scott Matushek, Mihai Giurcanu, Kathleen G. Beavis, Diego di Sabato, David Meltzer, Mark K. Ferguson, John P. Kress, Kumaran Shanmugarajah, Jeffrey B. Matthews, John F. Fung, Patrick C. Wilson, John C. Alverdy, Jessica S. Donington
118 [GO] 2020―Oct―06 The Impact of Novel Coronavirus COVID-19 on Non-Communicable Disease Patients and Health Systems: A Review Andrew Y. Chang, Mark R. Cullen, Robert A. Harrington, Michele Barry
119 [GO] 2020―Sep―25 Elevated markers of gut leakage and inflammasome activation in COVID-19 patients with cardiac involvement H Hoel, L Heggelund, DH Reikvam, B Stiksrud, T Ueland, AE Michelsen, K Otterdal, KE Muller, A Lind, F Muller, S Dudman, P Aukrust, AM Dyrhol-Riise, JC Holter, M Trøseid
120 [GO] 2020―Sep―25 Reply to “High frequency of Antiphospholipid Antibodies in Critically ill COVID-19 patients: a Link with Hypercoagulability?” L. Suárez-Pérez, R. Coto-Hernández, C. Suárez-Cuervo, L. Caminal-Montero
121 [GO] 2020―Sep―23 Clinical characteristics and outcomes of immunosuppressed patients hospitalized with COVID-19: experience from London N. Vaid, M. Ardissino, T. A. N. Reed, J. Goodall, P. Utting, M. Miscampbell, D. Condurache, D. L. Cohen
122 [GO] 2020―Sep―22 Clinical characteristics and predictors of the duration of SARS-CoV-2 viral shedding in 140 healthcare workers W. Liu, Y. Liu, Z. Xu, T. Jiang, Y. Kang, G. Zhu, Z. Chen
123 [GO] 2020―Aug―03 Use of the IL-6R Antagonist Tocilizumab in Hospitalized COVID-19 Patients Krish Patel, Ted A. Gooley, Neil Bailey, Megumi Bailey, Livia Hegerova, Ami Batchelder, Heather Holdread, Vanessa Dunleavy, Tyler Downey, Jens Frisvold, Samantha Megrath, Krystle Pagarigan, Jennie Szeto, Justin Rueda, Adel Islam, Cynthia Maree, Sonam Nyatsatsang, Sarah E. Bork, Anne Lipke, D. Shane O’Mahony, Teresa Wagner, Juan Pulido, John Mignone, Samuel Youssef, Matthew Hartman, Jason D. Goldman, John M. Pagel
124 [GO] 2020―Aug―03 Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID-19: a retrospective cohort study. Johannes Eimer, Jan Vesterbacka, Anna-Karin Svensson, Bertil Stojanovic, Charlotta Wagrell, Anders Sönnerborg, Piotr Nowak
125 [GO] 2020―Jul―30 COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease? M. F. Landecho, J. R. Yuste, E. Gándara, P. Sunsundegui, J. Quiroga, A. B. Alcaide, A. García-Layana
126 [GO] 2020―Jul―22 Cytokine storm syndrome in coronavirus disease 2019: A narrative review Y.-M. Gao, G. Xu, B. Wang, B.-C. Liu
127 [GO] 2020―Jul―11 The link between Vitamin D and Covid-19: distinguishing facts from fiction Peter Bergman
128 [GO] 2020―Jul―02 Perspective: Vitamin D deficiency and COVID-19 severity - plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2, and thrombosis (R1) Jonathan M Rhodes, Sreedhar Subramanian, Eamon Laird, George Griffin, Rose Anne Kenny
129 [GO] 2020―Jul―01 Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or underestimated risk factor? H. Luxenburger, L. Sturm, P. Biever, S. Rieg, D. Duerschmied, M. Schultheiss, C. Neumann-Haefelin, R. Thimme, D. Bettinger
130 [GO] 2020―Jun―30 Methylprednisolone added to tocilizumab reduces mortality in SARS-CoV-2 pneumonia: An observational study Francisco Sanz Herrero, Francesc Puchades Gimeno, Pilar Ortega García, Carolina Ferrer Gómez, María Dolores Ocete Mochón, Miguel García Deltoro
131 [GO] 2020―Jun―25 SARS-CoV-2 and biomimetics: What saves the planet will save our health P Stenvinkel, J Painer, PG Shiels, A Bansal, S Fereidouni, B Natterson-Horowitz, RJ Johnson, JJ Miranda
132 [GO] 2020―Jun―19 Beating the odds with systematic individualized care Nationwide prospective follow-up of all patients with COVID-19 in Iceland D Helgason, E Eythorsson, LB Olafsdottir, T Agustsson, S Ingvarsdottir, S Sverrisdottir, ED Ragnarsdottir, M Gottfredsson, O Gudlaugsson, R Palsson, RF Ingvarsson
133 [GO] 2020―Jun―12 High Frequency of Antiphospholipid Antibodies in Critically-ill COVID-19 Patients: a Link with Hypercoagulability? Marc Pineton de Chambrun, Corinne Frere, Makoto Miyara, Zahir Amoura, Isabelle Martin-Toutain, Alexis Mathian, Guillaume Hekimian, Alain Combes
134 [GO] 2020―Jun―07 Viral Infections and Their Relationship with Catastrophic Antiphospholipid Syndrome: A Possible Pathogenic Mechanism of Severe COVID-19 Thrombotic Complications Claudia Mendoza-Pinto, Ricardo O. Escárcega, Mario García-Carrasco, David J.O. Bailey, Jose Luis Gálvez-Romero, Ricard Cervera
135 [GO] 2020―Jun―04 Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States Zaid Imam, Fadi Odish, Inayat Gill, Daniel O'Connor, Justin Armstrong, Aimen Vanood, Oluwatoyin Ibironke, Angy Hanna, Alexandra Ranski, Alexandra Halalau
136 [GO] 2020―May―28 Sex-based dimorphism in the SARS-CoV2 virulence L. Pala, F. Conforti
137 [GO] 2020―May―27 COVID-19 and Renin-Angiotensin system inhibition - role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy? Aneta Aleksova, Federico Ferro, Giulia Gagno, Chiara Cappelletto, Daniela Santon, Maddalena Rossi, Giuseppe Ippolito, Alimuddin Zumla, Antonio P. Beltrami, Gianfranco Sinagra
138 [GO] 2020―May―26 Racial disparities in COVID-19 deaths reveal harsh truths about structural inequality in America A. Anyane-Yeboa, T. Sato, A. Sakuraba
139 [GO] 2020―Apr―30 Clinical and Epidemiological Characteristics of 1,420 European Patients with mild-to-moderate Coronavirus Disease 2019 Jerome R. Lechien, Carlos M. Chiesa-Estomba, Sammy Place, Yves Van Laethem, Pierre Cabaraux, Quentin Mat, Kathy Huet, Jan Plzak, Mihaela Horoi, Stéphane Hans, Maria Rosaria Barillari, Giovanni Cammaroto, Nicolas Fakhry, Delphine Martiny, Tareck Ayad, Lionel Jouffe, Claire Hopkins, Sven Saussez, Serge Blecic, Daniele R. De Siati, Pierre Leich, Christel Souchay, Camelia Rossi, Fabrice Journe, Julien Hsieh, Laurence Ris, Fahd El Afia, Bernard Harmegnies, Lea Distinguin, Younes Chekkoury-Idrissi, Marta Circiu, Philippe Lavigne, Irene Lopez Delgado, Christian Calvo-Henriquez, Chiara Falanga, Frederique Coppee, Serge D. Le Bon, Alexandra Rodriguez, Didier Dequanter, Jean-Philippe Cornelis, Sebastien Vergez, Lukas Koenen, Mannelli Giuditta, Gabriele Molteni, Manuel Tucciarone, Thomas Radulesco, Mohamad Khalife, Anne-Francoise Fourneau, Soraya Cherifi, Mario Manto, Justin Michel, Thomas Radulesco, Gabriele Molteni, Manuel Tucciarone, Giuditta Mannelli, Giovanna Cantarella
140 [GO] 2020―Apr―29 COVID-19 diagnosis and management: a comprehensive review Giuseppe Pascarella, Alessandro Strumia, Chiara Piliego, Federica Bruno, Romualdo Del Buono, Fabio Costa, Simone Scarlata, Felice Eugenio Agrò
141 [GO] 2020―Apr―15 Carving out a place for internal medicine during COVID-19 epidemic in Italy Marco Vincenzo Lenti, Gino Roberto Corazza, Antonio Di Sabatino
142 [GO] 2020―Apr―03 Familial hypercholesterolemia and COVID-19: triggering of increased sustained cardiovascular risk Alpo Vuorio, Gerald F. Watts, Petri T. Kovanen
143 [GO] 2020―Mar―27 Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19) Jian Wu, Wei Li, Xiaowei Shi, Zhongming Chen, Bin Jiang, Jun Liu, Dawei Wang, Chengyuan Liu, Yiling Meng, Leilei Cui, Jiong Yu, Hongcui Cao, Lanjuan Li
 [1] 

143 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec